Can surgery beat eye cancer in HIV patients? new study aims to find out
NCT ID NCT04704648
First seen Jan 10, 2026 · Last updated Jun 19, 2026 · Updated 19 times
Summary
This study looks at whether surgically removing a type of eye tumor called ocular surface squamous neoplasia (OSSN) is practical for people living with HIV in Sub-Saharan Africa. About 84 participants will have the tumor cut out and be followed for a year to see if the procedure is safe and if patients return for check-ups. The goal is to gather information for larger future studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HPV are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Uganda Cancer Institute
RECRUITINGKampala, Uganda
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
surgical excision
What this could lead to
If successful, this could show that surgical removal of these eye tumors is practical in this region, paving the way for better treatment access.
What could go wrong
This is an early feasibility study with only 84 participants, so results may not apply broadly. Surgery risks include infection or incomplete removal.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.